You are here: Industry Insights > Sirtex

News List

Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration prnasia
February 11, 2022
Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand Pharmaceutical Group Limited, that SIR-Spheres® Y-90 resin microspheres...
Sirtex Medical and China Grand Pharmaceutical announce successful first administration of SIR-Spheres® Y-90 resin microspheres in China prnasia
October 13, 2021
Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today that the first procedure of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres...
Sirtex Medical and BlackSwan Vascular, Inc. announce first patient enrolled in pivotal LAVA Study prnasia
April 20, 2021
Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a Bay Area-based private company developing groundbreaking therapies in endovascular embolization, announced that the first ...
Sirtex Medical announces new SIR-Spheres(R) DOORwaY-90 Study: The first prospective multicenter U.S.-based trial for registration as first-line treatment for hepatocellular carcinoma prnasia
March 23, 2021
Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, announced full FDA approval of the DOORwaY90 Study, a trial evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin ...
Sirtex Medical announces collaboration update with OncoSec Medical prnasia
January 20, 2021
Sirtex Medical US Holdings, Inc. announced an advancement in its strategic collaboration with OncoSec Medical, Inc. relating to OncoSec's lead product candidate TAVO™ (tavokinogene telseplasmid) and its electroporation (EP) gene delivery system.
Sirtex Medical appoints Kevin R. Smith as Chief Executive Officer En-CPhI.CN
October 17, 2019
Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, announced the appointment of Kevin R. Smith as Chief Executive Officer of Sirtex Medical Pty Ltd.